Introduction
============

High blood pressure (BP) affects up to a billion people worldwide and is an important risk factor for cardiovascular disease even at levels below those traditionally classified as hypertensive ([@B7]). In older people high BP is largely attributable to elevated systolic BP secondary to increased arterial stiffness ([@B8]).

Dietary measures offer potential as large-scale, cost-effective, and low-risk interventions that may offer a population-based strategy to complement drug-based therapy targeted at high risk individuals. Beetroot is a rich source of dietary inorganic nitrate ([@B18]). Inorganic nitrate is absorbed in the proximal small intestine and, *via* the enterosalivary circulation, can act as a source of nitrite anions and nitric oxide ([@B18]). Nitric oxide, which is endogenously produced by endothelial cells, is a vasodilator with a range of vasoprotective functions ([@B22]). Tissue and blood nitrite, derived either from oxidation of nitric oxide or dietary sources of nitrite/nitrate, serves as a reservoir from which nitric oxide can be produced through acidification or *via* proteins, including hemoglobin, that possess nitrite-reductase activity ([@B27]). This mechanism contributes to skeletal muscle vasodilation in response to hypoxia ([@B6]) and nitrite supplementation reduces the BP response to the metaboreflex in skeletal muscle in older adults ([@B26]). Inorganic nitrite supplementation has also been reported to improve endothelial dysfunction and decrease arterial stiffness in aged mice ([@B29]) and older humans with moderately elevated cardiovascular risk ([@B25]).

Previous studies have examined short-term effects of beetroot juice on brachial BP ([@B16]; [@B33]; [@B14], [@B13]; [@B9]; [@B10]), but little is known about its effect on aortic (central) BP. Aortic BP has been shown to better predict incident cardiovascular disease than brachial BP ([@B32]) and is more closely associated with vascular and cardiac target organ damage ([@B15]). Organic nitrates, while differing in some respects from inorganic nitrite/nitrate, also act via production of nitric oxide ([@B23]) and reduce aortic more than brachial BP ([@B11]). Whether dietary inorganic nitrate has similarly more marked effects on aortic pressure has not been studies. It is also established that ambulatory BP measured over 24 h is a better predictor of cardiovascular risk and total mortality than clinic measurements of BP ([@B3]), and recently it has become possible to measure aortic BP over 24 h ([@B34]).

We therefore hypothesized that dietary nitrate in beetroot juice would reduce aortic BP acutely after administration. We also aimed to examine its effect on aortic blood pressure over a 24-h period, arterial stiffness and other measures of vascular function, and to compare its effect on aortic and brachial systolic BP.

Materials and Methods {#s1}
=====================

Participants
------------

Fifteen healthy volunteers (eleven female and four male) consisting of medical students and members of staff of Imperial College London were recruited. Healthy participants aged over 18 years with no existing co-morbidities, including hypertension, or on any medication (other than oral contraceptive pill), were eligible for the study. Studies were performed at the International Centre for Circulatory Health, Imperial College London, United Kingdom. The study protocol was approved by the London-Fulham Research Ethics Committee, Charing Cross Hospital (Ref: 13/LO/0063). All participants gave written informed consent in accordance with the principles of the Declaration of Helsinki.

Study Design and Interventions
------------------------------

This study was designed as a double-blind, randomized, placebo-controlled crossover trial ([Figure 1](#F1){ref-type="fig"}), all observers were blinded to allocation status and participants were randomized using a computer program. All individuals were required to abstain from drinking caffeine-containing beverages alcohol and smoking for 12 h prior to study days and during the study. During the 24-h period following ingestion of the study drinks, no other dietary restrictions were imposed except that participants were asked not to consume any food or drink containing beetroot. A "washout" period of at least 24 h and less than 7 days was chosen on the basis of the duration of action of beetroot seen in other studies ([@B5]; [@B4]). Ingestion of study drinks was performed at the same time of day.

![Diagram showing crossover design. Timings of measurements of clinic blood pressure (BP), carotid-femoral pulse wave velocity (cfPWV), and ambulatory blood pressure monitoring (ABPM) with respect to administration of placebo or active juice (time = 0) are indicated by the arrows and bars, respectively. ABPM was performed every 30 min during the day and hourly during the night.](fphys-10-00047-g001){#F1}

The active intervention containing dietary nitrate was administered as a 70 ml concentrated beetroot juice drink (Beet It Sport Stamina, Beet It Beetroot Products Company) which contained 6.5--7.3 mmol nitrate. "Nitrate-free" beetroot juice (containing \<0.06 mmol nitrate) from the same company which was identical in appearance acted as placebo.

Study Measurements
------------------

A questionnaire was administered to collect information on lifestyle, and personal and family medical history. Height was measured using a stadiometer and weight was measured using a Soehnle electronic scale.

Sitting clinic BP (aortic and brachial) and heart rate were measured using a Pulsecor device (Pulsecor, Auckland, New Zealand) ([@B24]). Measurements of BP were made at 20, 10, and 5 min and immediately prior to ingestion of the active of placebo drink. Subsequent measurements of BP were made at 5, 10, 15, 30, and 60 min after ingestion. After the final Pulsecor measurement at 60 min, a 24 h BP monitoring device (Mobil-O-Graph^®^), which measures both aortic and brachial BP ([@B34]), was fitted to the participant's non-dominant arm. The Mobil-O-Graph^®^ recorded BP at 30-min intervals throughout the day, and at hourly intervals during the night.

Carotid-femoral pulse wave velocity (cfPWV) was measured using a Vicorder device (Skidmore Medical Limited, Bristol, United Kingdom) applied to the neck and right thigh of all subjects according to current guidelines ([@B31]). cfPWV was measured approximately 20 min before and 30 min after ingestion of active or placebo drink. An indirect estimate of aortic pulse wave velocity (iPWV) during 24 h BP measurement was also obtained from the Mobil-O-Graph^®^ as previously described ([@B19]).

Sample Size Determination and Statistical Analysis
--------------------------------------------------

The sample size was chosen to detect a 4 mmHg treatment difference in the primary endpoint, aortic systolic BP (alpha = 0.05; 80% power) assuming a standard deviation (SD) of 5 mmHg.

Statistical analysis and randomization was performed using R 3.0.2. Sample characteristics are presented as mean ± SD for normally distributed data or median (25th, 75th centiles) for skewed data, or n (%) for categorical data. Results are presented as the treatment effect (95% confidence interval). Data were analyzed by means of linear mixed models with random intercepts and common slopes to study the treatment effect, adjusting for baseline measures immediately prior to ingestion. The assessment of period effects and interactions between period and treatment was done within the models by including a covariate for the period in which the treatment was given, and a covariate representing the interaction between the period and the treatment. When no evidence of period effects or interactions between period and treatment was found, these covariates were excluded using an analysis of deviance, which led to a final, more parsimonious, model. Model assumptions were verified by analyzing residuals plots, and robust linear mixed models were used when assumptions were violated. All statistical tests were two-sided and statistical significance for the primary endpoint was set at *p* \< 0.05.

Results
=======

Participant characteristics are shown in [Table 1](#T1){ref-type="table"}; volunteers were predominantly young females, only two individuals smoked, body mass index was in the healthy range and alcohol intake was moderate.

###### 

Participant characteristics at recruitment, pre-intervention.

  Characteristics                          Value
  ---------------------------------------- -------------------
  Number of participants                   15
  Male                                     4 (26.7%)
  Age, years                               29.2 ± 8.3
  Height, cm                               166.0 ± 9.6
  Weight, kg                               67.2 ± 15.9
  Body mass index, kg/m^2^                 23.4 (21.3, 24.6)
  Brachial systolic blood pressure, mmHg   108.1 ± 7.2
  Aortic systolic blood pressure, mmHg     100.4 ± 7.4
  Diastolic blood pressure, mmHg           67.8 ± 5.37
  Heart rate, beats/min                    64.7 (58.3, 71.3)
  cfPWV, m/s                               5.71 ± 0.79
  iPWV, m/s                                5.67 ± 0.96
  Alcohol, units/week                      6.1 ± 5.7
  Current smoking, n (%)                   2 (11.1%)
                                           

Values are mean ± SD or median (inter-quartile range) for skewed data. Categorical data are shown as n (%).

Clinic Measurements
-------------------

Ingestion of beetroot juice containing nitrate resulted in a lower aortic systolic BP at 30 min (primary endpoint) compared with placebo \[difference (Δ) = -5.2 (-8.2, -2.2) mmHg; *p* \< 0.01; [Table 2](#T2){ref-type="table"}\]. Aortic systolic BP remained lower at 60 min after beetroot juice ingestion, although the difference was smaller \[-3.2 (-6.6, 0.2) mmHg; [Table 2](#T2){ref-type="table"}\].

###### 

Treatment effects and 95% confidence intervals of clinic measurements 30 and 60 min post-ingestion of beetroot juice compared to placebo.

  Variable             Treatment effect (95% confidence interval)   
  -------------------- -------------------------------------------- ------------------
  Aortic SBP, mmHg     -5.2 (-8.2, -2.2)^∗^                         -3.2 (-6.6, 0.2)
  Brachial SBP, mmHg   -0.8 (-5.3, 3.6)                             -0.7 (-4.3, 2.9)
  DBP, mmHg            -2.0 (-4.4, 0.4)                             -0.5 (-3.0, 2.1)
  cfPWV, m/s           -0.1 (-0.3, 0.2)                             --
  Heart rate, bpm      -2.2 (-5.9, 1.3)                             -2.0 (-6.2, 2.2)
                                                                    

SBP, systolic blood pressure; DBP, diastolic blood pressure; cfPWV, carotid-femoral pulse wave velocity.

∗

Primary outcome (p \< 0.01).

In contrast brachial systolic BP did not differ noticeably between active and placebo groups at 30 or 60 min post-ingestion, BP in the active group was slightly lower \[-0.8 (-5.3, 3.6)/-2.0 (-4.4, 0.4) mmHg; [Table 2](#T2){ref-type="table"}\] but the confidence intervals of both brachial systolic and diastolic BP included zero.

There was no evidence of either a period effect or a treatment x period interaction for either aortic or brachial systolic pressure. Effects on heart rate and cfPWV are shown in [Table 2](#T2){ref-type="table"}. None of these measurements differed between active and placebo drink at 30 or 60 min post-ingestion.

Ambulatory Blood Pressure Measurements
--------------------------------------

Average 24-h aortic systolic BP was -0.9 (-2.5, 0.7) mmHg (lower) after beetroot juice ingestion than after placebo but the 95% confidence interval included zero. Differences between treatments were small and confidence intervals included zero for all other ambulatory BP variables, including iPWV ([Table 3](#T3){ref-type="table"}). [Supplementary Figures S1](#SM1){ref-type="supplementary-material"}--[S6](#SM1){ref-type="supplementary-material"} show the ambulatory measurements over the 24-h period, for active treatment and placebo.

###### 

Treatment effects and 95% confidence intervals of 24 h ambulatory measurements after beetroot juice ingestion compared to placebo.

  Variable                  Treatment effect (95% confidence interval)
  ------------------------- --------------------------------------------
  Aortic SBP, mmHg          -0.9 (-2.5, 0.7)
  DBP, mmHg                 -0.3 (-1.8, 1.3)
  Heart rate, bpm           -1.90 (-3.7, 0.1)
  iPWV, m/s                 -0.04 (-0.10, 0.01)
  Reflection magnitude, %   1.4 (-0.0, 2.7)
  Augmentation index, %     -0.7 (-2.4, 0.9)
                            

SBP, systolic blood pressure; DBP, diastolic blood pressure; iPWV, indirect aortic pulse wave velocity.

Adverse Events
--------------

There were no major adverse events. All participants were asked if they experienced any headaches, flushing or light-headedness; one participant complained of headache after consuming beetroot juice containing nitrate (active). This headache lasted for approximately 10 min. No other symptoms were reported by any of the participants.

Discussion
==========

This randomized, double blind, placebo-controlled crossover study has demonstrated that beetroot juice containing ∼7 mmol inorganic nitrate lowers aortic systolic BP by ∼5 mmHg compared with placebo, with the peak effect occurring approximately 30 min after ingestion. The effect of beetroot juice containing inorganic nitrate was more marked on aortic than brachial systolic BP and there was little or no effect of ingestion of inorganic nitrate on subsequent 24-h aortic BP.

Previous studies have examined the effect of dietary nitrate on brachial BP. [@B14] found that, compared with water, beetroot juice containing 5.5 mmol nitrate caused a peak reduction in brachial systolic BP of ∼5 mmHg at 3 h with no change in diastolic BP. It is possible that differences in drink composition or participant characteristics contributed to the greater effect on brachial BP seen in their study. For example, participants in their study typically had brachial systolic BP of ∼120 mmHg compared with 110 mmHg in our study and the effect of hypotensive agents tends to be greater with higher baseline BP ([@B21]). Also, ingestion of water has been reported to increase brachial BP ([@B12]), probably through a mechanism involving the sympathetic nervous system and elicited by hypo-osmolarity ([@B20]); while this effect appears small in young individuals ([@B12]) it may mean that water is an unsuitable control for beetroot juice. In another study, Coles and Clifton compared a beetroot and apple drink (∼7.5 mmol nitrate) with apple juice on 24-h systolic or diastolic BP, and found no significant effect, although they reported a non-significant ∼4 mmHg difference between active and placebo group 6 h after consumption ([@B4]). We found minimal effects of nitrate-containing beetroot juice on brachial systolic BP, so our data suggest that measurement of brachial BP as opposed to aortic BP is likely to have underestimated the effect of inorganic nitrate in some previous studies. [@B28] conducted a meta-analysis and systematic review of 12 studies using beetroot juice supplementation and demonstrated a change in brachial systolic BP of -4.5 mmHg (95% CI: -6.4, -2.5; *p* \< 0.001) with nitrate doses ranging from 5.1 to 45 mmol. In the meta-regression these researchers carried out, the mean differences in systolic BP were not correlated with study duration. In keeping with our findings, ambulatory BP was not lowered by beetroot juice in the two studies of normotensive individuals included in the systematic review ([@B4]; [@B10]).

Our study has strengths and limitations. A randomized double-blind placebo control study is a robust design; the sample size is small but adequate to detect a clinically important reduction in BP. Many previous studies have not been blinded as low-nitrate water or isomolar potassium and sodium chloride solutions have been used as the placebo ([@B16]; [@B33]; [@B14]; [@B17]; [@B2]; [@B10]). Our data are limited in that they were conducted in young healthy individuals receiving a single dose of beetroot juice and may not generalize to older people with or without high BP, or to other dosing regimens or durations of administration. Additionally, our study only considered the hypotensive effect of inorganic nitrate in beetroot juice. A recent meta-analysis ([@B1]) has provided evidence that beetroot juice may contain factors other than nitrate that lower BP; given the design of our study it is not possible to conclude anything about the effect of other factors in beetroot juice on BP.

It has been suggested that beetroot juice may have value as a population-based intervention to lower BP, although our data showing an apparently short duration of BP lowering raise questions regarding its usefulness in younger normotensive individuals. Nevertheless, even small reductions in BP could lead to a large reduction in incident cardiovascular disease on a population level ([@B30]). Dietary approaches to BP reduction could be useful in the face of the rising incidences of both obesity and diabetes. It remains to be established whether dietary supplementation with beetroot juice or other nitrate-rich vegetables, extracts or juices, is an effective, safe and acceptable method of population-scale BP reduction.

Conclusion
==========

In conclusion, nitrate-contained in beetroot juice lowered aortic systolic BP in normotensive individuals 30 min post-ingestion with minimal effects on brachial BP. This effect was of comparatively short duration and did not persist over 24-h. Previous studies only measuring brachial BP and not aortic BP may have underestimated the effects of inorganic nitrates on BP.
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